CHRISTINA BORSELLI: Open Payments
NPI 1891348181 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $182 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Ozempic, Kerendia, REXULTI, AMVUTTRA, LOKELMA.
Industry payments across WA — which companies pay providers there.
